Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreUtilising the extensive range of data assets exclusively available to IQVIA, combined with our market leading expertise, we are able to support the NHS meet the challenge of delivering high quality, efficient and cost effective healthcare by identifying actionable insight and realising the value in data.
Learn MoreWe believe in the UK’s potential to become a global leader in the life sciences sector, and our investments announced in the 2018 Second Life Sciences Sector Deal further support the UK Government and the industry’s aim to make that potential a reality.
Learn MoreWe are committed to providing solutions that inform and enable all stakeholders across UK healthcare, to innovate with confidence, maximise opportunities, and, ultimately, drive human health outcomes forward.
Learn MoreIQVIA’s Pharmacy Communications offers pharma companies a simple and cost-effective channel to communicate product changes, updates and patient advice directly to patients via pharmacists.
Learn MoreExplore our library of resources spanning the healthcare & life science ecosystem on the latest topics, trends, and market developments that matter to you.
Learn MoreIn an ever-changing health economy, with tightening regulations and a focus on cost effectiveness, a thorough understanding of the healthcare environment and a well-considered market access strategy are vital for pharma to effectively communicate their service offering.
This ensures products and services are delivered to the right people and in the right way, at the right time. Most importantly, it allows patients struggling with conditions to access treatments and medicines capable of improving their health.
Interface Clinical Services, an IQVIA business, deliver clinical review services to primary care through a nationwide team of clinical pharmacists. It enables the pharmaceutical industry to effectively engage with the NHS and the wider healthcare environment. It also helps:
The Interface Clinical Services team delivered a clinical review of high-risk asthmatic patients across a Health Care Partnership spanning 52 medical practices. 13 pharmacists supported over 18,000 NHS patients over 4 months. Patients benefited from 5,488 medicinal interventions, including 1,582 patients who were initiated on a treatment. 59% of patients invited, attended pharmacist-led clinics and received personalised guidance and education.
In a COVID-19 environment, this clinical review enabled the Health Care Partnership to: